The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

June 30, 2010

Conditions
Pediatric NeoplasmQuality of LifeOutcome AssessmentPalliative Care
Interventions
OTHER

Routine Data collection

"Patients assigned to the control arm answered PediQUEST (PQ) surveys at most once a week and at least once a month. PQ-surveys were administered through a tablet computer if patient was at the clinic or ward or over the phone if patient was primarily at home. PQ-survey had 9 age- and respondent- adapted versions.~Control arm participants reported their satisfaction with the PediQUEST technology twice 4th and 8th PediQUEST administration. These surveys were embedded in PediQUEST."

OTHER

Feedback of patient-reported outcomes

Patients, parents and primary providers received printed reports summarizing patient/parent reported outcomes for last five visits. When child reported moderate-severe distress an email was automatically sent to primary providers (oncologist, nurses and psychosocial clinicians), as well as to the pain and palliative care services.

Trial Locations (4)

19104

Children's Hospital of Philapdelphia, Philadelphia

98105

Seattle Children's Hospital, Seattle

02115

Boston Children's Hospital, Boston

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT01838564 - The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology | Biotech Hunter | Biotech Hunter